$AIP

Alpern Paul L sold $83K of AIP

Alpern Paul L (VP and General Counsel) sold 4,000 shares of Arteris, Inc. (AIP) at $20.77 on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Alpern Paul L
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The transaction is small and pre‑arranged, so it likely has minimal impact on AIP's stock.

02

Market read

Routine insider sale with modest size; limited trading relevance.

03

What to watch

Insider retains 70,733 shares, representing a substantial stake.

Relevance 2/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider trades and are used to gauge insider sentiment.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

VP and General Counsel Paul L. Alpern sold 4,000 shares for $83,063 via a 10b5-1 plan.

Expected impact

Potential slight downward pressure, unlikely to move price materially.

Evidence & confidence

The sale is modest ($83k) and follows a pre‑arranged plan, so market reaction is expected to be minimal.

Market effects

No significant impact on the semiconductor design sector.

Limited to U.S. investors tracking insider activity.

Low; the filing is a routine insider transaction.

Counterpoint

The sale could be a tax‑planning move rather than a lack of confidence.

Key entities

  • Arteris, Inc.

    Provider of IP for semiconductor design.

  • Paul L. Alpern

    Vice President and General Counsel of Arteris.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to